<DOC>
	<DOCNO>NCT00048828</DOCNO>
	<brief_summary>This study compare clozapine olanzapine ( ZyprexaÂ® ) treatment child adolescent fail standard antipsychotic treatment schizophrenia .</brief_summary>
	<brief_title>Treating Drug-Resistant Childhood Schizophrenia</brief_title>
	<detailed_description>Schizophrenia devastate illness regardless age present . When disorder occur childhood adolescence , consequence term functional impairment , loss developmental opportunity , family societal burden particularly dramatic . Evidence support improve efficacy and/or side effect profile atypical antipsychotic medication adult . Thus , essential examine whether potential benefit agent extend child , particularly child fail standard treatment . Patients randomly assign receive either clozapine olanzapine daily 12 week . Patients meet study team week discus progress record side effect . Three parent meeting take place study . During meeting , question discuss support education schizophrenia give parent . Various scale measure psychotic , manic , aggressive , depressive symptom use assess patient .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Schizophrenia , Childhood</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Inclusion criterion : DSMIV criterion treatmentrefractory schizophrenia schizoaffective disorder Willingness use acceptable form birth control , applicable Neurological medical disorder would contraindicate treatment clozapine olanzapine IQ le 70 DSMIV criterion substance ( caffeine nicotine ) relate disorder Failure adequate trial olanzapine clozapine</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>